Therefore, the effectiveness of this activation pathway may be impacted by the presence of a specific variation in the Furin gene, which may affect the virus ability to infiltrate and infect human cells, in turn modifying the severity of COVID-19 outcomes. This evidence concerns the gene FURIN and COVID-19.